Study With Two Coenzyme Q10 Products

University of Primorska25 enrolled

Overview

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

DOUBLE

Enrollment

Conditions

Coenzyme Q Deficiency

Interventions

Dietary supplement - Active comparatorDIETARY_SUPPLEMENT

Single dose intervention with Standard product Coenzyme Q10 (ubiquinone); 2 capsules - 100 mg total coenzyme Q10

Dietary supplement - Experimental productDIETARY_SUPPLEMENT

Single dose intervention with Experimental product; BMT® coenzyme Q10; 2 capsules - 100 mg total coenzyme Q10

Eligibility

Sex: ALLMin age: 50 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * subject informed consent form * aged between 50 and 65 years old * body mass for women 70± 5 kg and for men 85± 5 kg * non-smoking * healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases * absence of any prescribed medication during the study * willing to avoid a consumption of any food supplements at least 2 weeks before and during the study Exclusion Criteria: * cardio-vascular diseases, diabetes, neurodegenerative diseases, gastrointestinal disorders, pregnancy, breast-feeding * intake of any food supplements within two week of the beginning of the study * drug or alcohol abuse

Locations (1)

University of Primorska, Faculty of Health Sciences

Izola, Izola, Slovenia